Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
J Neurol Sci ; 314(1-2): 161-2, 2012 Mar 15.
Article in English | MEDLINE | ID: mdl-22093143

ABSTRACT

Spontaneous cervical-artery dissection (CAD) is a major cause of cerebral ischaemia in young adults. While their pathophysiology remains still poorly understood, CAD is considered today as a multifactorial disease determined by general and local predisposing factors; these predisposing factors being predominantly constitutional abnormalities of the arterial wall. Here, we report an MRI-confirmed dissection of a duplicated vertebral artery, in a patient with attacks of vertigo due to cerebellar infarction following a minor neck trauma. Knowing that another case of vertebrobasilar CAD on a duplicated vertebral artery has been reported, these rare anatomical variants probably predispose to vertebral CAD, via local histological defects or significant hemodynamics alterations, as reported for the classical local predisposing conditions for vertebral dissection, i.e.: fibromuscular dysplasias or carotid redundancies (including loops, kinks and coils).


Subject(s)
Vertebral Artery Dissection/etiology , Vertebral Artery/abnormalities , Cerebellar Diseases/etiology , Cerebellar Diseases/pathology , Cerebral Angiography , Cerebral Infarction/etiology , Cerebral Infarction/pathology , Craniocerebral Trauma/complications , Humans , Magnetic Resonance Angiography , Magnetic Resonance Imaging , Male , Middle Aged , Soccer/injuries , Tomography, X-Ray Computed , Vertebral Artery/pathology , Vertebral Artery Dissection/pathology , Vertigo/etiology
2.
Bull Acad Natl Med ; 195(4-5): 987-1000; discussion 1000-1, 2011.
Article in French | MEDLINE | ID: mdl-22375365

ABSTRACT

Contrasting with the abundant literature dedicated to atrial fibrillation (AF) and to the use of new oral anticoagulants in this setting, very few recent studies have focused on patients with AF-associated stroke. From November 2010 to March 2011, we conducted a small prospective 4-month study in the stroke units of Lariboisière and Bicêtre hospitals. Fifty patients with FA and stroke were included (14% of all strokes), including 45 patients with cerebral infarcts (CI), 3 with transient ischemic attacks (TIA) and 2 with intracerebral hemorrhage (ICH). The results of this study, together with a review of the sparse relevant literature, underline the following points: these patients tend to be older and more frequently female than in recent clinical trials; TIAs are rare; these patients have numerous vascular risk factors and associated cerebrovascular diseases such as atheroma and leukoaraiosis; CI is often extensive and hemorrhagic; AF is discovered in a stroke unit in 40% of cases and is paroxystic in 33% of cases, with no consensus on the potential regulation; there is massive underuse of VKA in patients with known AF; rtPA intravenous thrombolysis is frequent; treatment difficulties arise in patients with AF-related CI and a history of ICH; the prognosis of VKA-related ICH is poor; the use of oral anticoagulants alone or combined with aspirin is controversial in case of AF associated with severe atheroma. Patients with AF seen in stroke units are therefore very different from those seen by cardiologists: they are older and have many vascular risk factors, stroke, and other cerebrovascular lesions, raising difficult treatment issues owing to the dual risk of embolic recurrence and symptomatic hemorrhagic transformation. In addition, contraindications to long-term VKA use are frequent. Many of these issues will again be raised with the arrival of new oral anticoagulants.


Subject(s)
Atrial Fibrillation/complications , Stroke/etiology , Aged , Aged, 80 and over , Anticoagulants/therapeutic use , Contraindications , Female , Fibrinolytic Agents/therapeutic use , Hospital Units , Humans , Intracranial Hemorrhages/etiology , Male , Middle Aged , Prospective Studies , Risk Factors , Stroke/therapy , Thrombectomy , Tissue Plasminogen Activator/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...